Terms: = Lymphoma AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Clinical Outcome
2 results:
1. Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and bcl3) is Associated With clinical outcome of NSCLC Patients.
Dimitrakopoulos FD; Antonacopoulou AG; Kottorou AE; Panagopoulos N; Kalofonou F; Sampsonas F; Scopa C; Kalofonou M; Koutras A; Makatsoris T; Dougenis D; Papadaki H; Brock M; Kalofonos HP
Sci Rep; 2019 Oct; 9(1):14299. PubMed ID: 31586084
[TBL] [Abstract] [Full Text] [Related]
2. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
[TBL] [Abstract] [Full Text] [Related]
